Enorama Pharma AB (publ) (STO:ERMA)

Enorama Pharma AB Revenue

Enorama Pharma AB had revenue of -34.00K SEK in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 1.77M, down -83.60% year-over-year. In the year 2025, Enorama Pharma AB had annual revenue of -6.74M. That makes Enorama Pharma AB the 45,738th largest company in the world by revenue and 732nd in Sweden.

• Revenue (ttm): 1.77M
• Revenue Growth: -83.60%
• P/S Ratio: 37.63
• Revenue / Employee: 361.75K
• Employees: 4
• Market Cap: 78.32M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-6.74M	-34.35M	-
Dec 31, 2024	27.61M	26.49M	2,363.16%
Dec 31, 2023	1.12M	-8.32M	-88.13%
Dec 31, 2022	9.44M	-3.50M	-27.06%
Dec 31, 2021	12.95M	7.83M	152.77%
Dec 31, 2020	5.12M	-5.41M	-51.38%
Dec 31, 2019	10.54M	-1.55M	-12.83%
Dec 31, 2018	12.09M	10.09M	506.07%
Dec 31, 2015	1.99M	611.00K	44.18%
Dec 31, 2014	1.38M	-	-

Data Source: Fiscal.ai Last updated: Aug 19, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 12, 2026

Data Sources Report a data error